Riga, Latvia

Arnis E Duk

This inventor holds 1 USPTO granted patent. Top assignees: Institut Bioorganicheskoi Khimii Imeni M.m. Shemyakina Akademii Nauk Ssr, Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnis E Duk. Retrieved from https://idiyas.com/inventor/arnis-e-duk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnis E Duk and His Contribution to Interferon Research.

Introduction

Arnis E Duk is an inventor associated with Riga, Latvia. His recorded patent concerns human leukocyte interferon and a method for producing it in bacteria.

Latest Patents

Duk is listed as an inventor on 1 patent: “Human Leukocyte Interferon N and a Method of Producing Same in Bacterial.” The invention focuses on producing human leukocyte interferon using bacterial methods.

Career Highlights

Duk’s listed institutional affiliations include the Institute of Bioorganic Chemistry named after M. M. Shemyakin of the USSR Academy of Sciences and the Institute of Organic Synthesis of the Latvian Academy of Sciences. These affiliations place his work within research institutions focused on chemistry and related scientific fields.

Collaborations

Duk’s listed coworkers include Andris V Dishler and Alexandr A Smorodintsev. Their names are associated with his research and patent record.

Conclusion

Arnis E Duk’s patent documents a contribution to research on producing human leukocyte interferon in bacteria, alongside his connections to scientific institutions and fellow researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…